Recent

% | $
Quotes you view appear here for quick access.

Schnitzer Steel Industries, Inc. Message Board

ajetjock 56 posts  |  Last Activity: Feb 23, 2015 8:35 AM Member since: Mar 11, 1998
SortNewest  |  Oldest  |  Highest Rated Expand all messages
  • At November 30, 2014, Intellipharmaceutics' cash and cash equivalents totaled $4.2 million, compared with $0.8 million at November 30, 2013. The increase in cash during the year ended November 30, 2014 is mainly a result of the decrease in cash flows used in operating activities due to payments received from the commercial sales of our generic Focalin XR (R) (dexmethylphenidate hydrochloride extended-release) capsules for the 15 and 30 mg strengths;

    Sentiment: Strong Buy

  • ajetjock ajetjock Feb 15, 2015 9:23 PM Flag

    And this is the beauty of this stock: Only 13 institutions and 3 funds hold it. IOW, it is NOT yet discovered if you will.

    Now add the very low float + low PPS.

    A no brainer.

    With such profit margins all they have to do is increase production and the numbers will follow.

    ...and so will the PPS.

    Sentiment: Strong Buy

  • "This has been a highly constructive quarter," said SinoCoking CEO Mr. Jianhua Lv. "The rapid and successful launch of our aboveground syngas facility has demonstrated SinoCoking's ability to redefine itself as a producer of clean energy products. With this transition into the clean energy space, we are creating new revenue and profit centers that we expect to improve the company's financial results going forward, and at the same time mitigate negative impact on operations related to softness in the traditional coal and coking businesses."

    Now under construction at the site of SinoCoking's first aboveground facility, which currently produces 25,000 cubic meters of syngas per hour, is a second facility with a similar capacity target. When completed and operating at full capacity -- expected toward the end of March 2015 - the two facilities' combined syngas output of 50,000 cubic meters per hour is expected to rank among the highest syngas production for any coking plant in China. Additionally, the company believes these first two facilities are the only ones in China that, to date, combine coking and syngas in parallel.

    SinoCoking also said that completion of the first phase of its underground coal gasification facility, expected later this month, should enable the company to produce an additional 60,000 cubic meters of syngas per hour, and that the ultimate goal is to expand output of that facility's capacity to 880,000 cubic meters of syngas per hour by the end of fiscal year 2018.

    Previously, during construction of the first aboveground facility last summer, Mr. Lv had estimated gross profit margin on syngas sales of between 45 and 50 percent based on a price of $0.139 per cubic meter. Since the company began selling syngas in October 2014, the actual gross profit margin has been 40.6 percent based on an average price of $.10 per cubic meter. "Even though the actual price and gross profit are below what we had anticipated initially, the gross profit margin fro

    Sentiment: Strong Buy

  • Reply to

    Love IPCI, afraid of an IPO? Any thoughts

    by zzpots111 Feb 9, 2015 4:05 PM
    ajetjock ajetjock Feb 9, 2015 7:06 PM Flag

    ZZ.

    There is NO IPO coming. IPCI is already a public stock.

    The float is MINIMAL, thus you should not concern yourself much with dilution.

    What you SHOULD concern yourself with, are LYING stock MANIPULATORS : Gregory, Meifud and Peckstein.

    IPCI's fundamentals are just fine.

    Sentiment: Strong Buy

  • ajetjock ajetjock Feb 9, 2015 11:07 AM Flag

    I have always wondered about their patents.

    Over the years we have seen them registering a lot of patents. While insiders keep on accumulating shares.

    Could there be a value to these patents the average Joe Investors fails to see ?

    Sentiment: Strong Buy

  • Reply to

    IPCI Manufacturing

    by wimuskyfisherman Feb 2, 2015 7:33 PM
    ajetjock ajetjock Feb 9, 2015 8:58 AM Flag

    YES ! This is a big deal.

    Also notice the variable drug baskets within IPCI's pipeline. IPCI is not only about generics ! and not only about timed release as some would like us to think.

    Sentiment: Strong Buy

  • Reply to

    Nay Sayers getting scared....

    by samsa1 Feb 5, 2015 2:31 PM
    ajetjock ajetjock Feb 5, 2015 2:47 PM Flag

    Absolutely !

    There is NO way they are just here because they "just don't like the Co"...unless they are insane...

    Who else aside from : Gregory, Meifud and Peckstein...will waste YEARS, on a board of a Co the don't like , just 'cuz they don't "like".

    Also as you insinuate, they are NOT IPCI stockholders, or they could have just bail out.

    I agree with you: They CLEARLY are here with an obvious agenda : MANIPULATE the price down.

    As ILLEGAL as it is...

    I also agree that they ARE worried, since in spite of their attempts at FEAR spreading, lies, and creating doubts...the price is NOT going lower.

    Eventually we WILL get the next approval, possibly more...price WILL move substantially higher, and the bashers will shut up for a while. As they will obviously realize how ridiculous they will appear.

    Never fails.

    Sentiment: Strong Buy

  • Reply to

    I Dont Get IT!

    by themanf20 Feb 5, 2015 10:50 AM
    ajetjock ajetjock Feb 5, 2015 11:34 AM Flag

    True !

    And I expect even MORE institutions to join as a result of the new CFO's activity.

    Sentiment: Strong Buy

  • Top Institutional Holders
    Concentration of Current % Held
    Top 10 Institutions: Ownership by top 10 institutions Top 20 Institutions: Ownership by top 20 institutions Top 50 Institutions: Ownership by top 50 institutions All: Ownership by all institutions
    Low
    Avg. Turnover Rating

    Name
    Shares Held
    Position Value
    Percentage of
    Total Holdings
    since 2/5/15
    % Owned
    of Shares
    Outstanding Turnover
    Rating
    Odidi Holdings, Inc.

    6.0M $23,093,293 +71% 25.7% Low
    Tekla Capital ...

    1.4M $3,154,106 +17% 6.0% Moderate
    Oppenheim Asset ...

    192.7K $583,397 +2% 0.8% Low
    Medical Strategy ...

    182.2K $523,714 +2% 0.8% Moderate
    Allport (John N)

    110.6K $425,684 +1% 0.5% Low
    Morgan Stanley ...

    96.6K $292,492 +1% 0.4% Low
    NHP Asset ...

    75.0K $227,090 +1% 0.3% Moderate
    Dafna Capital ...

    72.8K $220,389 +1% 0.3% Moderate
    First Midwest ...

    46.7K $104,849 +1% 0.2% Low
    Susquehanna ...

    42.1K $127,576 +1% 0.2% Moderate
    Top Mutual Fund Holders
    Percentage of Outstanding Shares per Holdings Style

    Sector Specific 6.3%
    International 0.7%
    Specialty 0.0%
    Core Growth 0.0%
    Index 0.0%
    Low
    Avg. Turnover Rating

    Name
    Shares Held
    Position Value
    Percentage of
    Total Holdings
    since 2/5/15
    % Owned
    of Shares
    Outstanding Investment
    Style
    H&Q Healthcare ...

    828.4K $2,508,164 +10% 3.6% Sector Specific
    H&Q Life ...

    575.6K $1,742,961 +7% 2.5% Sector Specific
    FCP OP Medical ...

    164.4K $497,660 +2% 0.7% International
    PHARMA /wHEALTH Fund

    28.3K $85,737 0% 0.1% Sector Specific
    RIM Global Fund ...

    17.9K $51,357 0% 0.1% Sector Specific
    Fidelity NASDAQ ...

    5.0K $11,206 0% 0.0% Index
    CF Equities HAIG ...

    660.0 $1,483 0% 0.0% Core Grow

    Sentiment: Strong Buy

  • Reply to

    pathetic jamokes, shlomo and samsa

    by pechstein.carl Feb 5, 2015 8:32 AM
    ajetjock ajetjock Feb 5, 2015 8:49 AM Flag

    Is that a THREAT Carl ?

    Enlighten me.

  • ajetjock ajetjock Feb 4, 2015 9:47 PM Flag

    Ahhh...another shorty "buzz word" dilution...

    Here is another FACT you bigoted fool: FLOAT !

    Contrary to your "dilution" BS , IPCI is acting VERY responsibly by keeping the dilution to a minimum.

    Hence the LOW float : a minimal 17 Million.

    ... Which is exactly why you and the other two stooges are here !

    Easier to MANIPULATE low float stocks.

    Sadly, most of the longs have seen the three of you at work here for a while.

    You are running out of CREDIBLE threat .

    Or more likely you are running out of believable LIES.

    Stick with your 8-5 job bigot. You suck at bashing.

    Sentiment: Strong Buy

  • Must be running out of new material.

    So even though we HAVE debunked your new/old lie, lets do it again :

    Institutional holdings in IPCI

    Top Institutional Holders
    Concentration of Current % Held
    Top 10 Institutions: Ownership by top 10 institutions Top 20 Institutions: Ownership by top 20 institutions Top 50 Institutions: Ownership by top 50 institutions All: Ownership by all institutions
    Low
    Avg. Turnover Rating

    Name
    Shares Held
    Position Value
    Percentage of
    Total Holdings
    since 2/4/15
    % Owned
    of Shares
    Outstanding Turnover
    Rating
    Odidi Holdings, Inc.

    6.0M $23,093,293 +71% 25.7% Low
    Tekla Capital ...

    1.4M $3,154,106 +17% 6.0% Moderate
    Oppenheim Asset ...

    192.7K $583,397 +2% 0.8% Low
    Medical Strategy ...

    182.2K $523,714 +2% 0.8% Moderate
    Allport (John N)

    110.6K $425,684 +1% 0.5% Low
    Morgan Stanley ...

    96.6K $292,492 +1% 0.4% Low
    NHP Asset ...

    75.0K $227,090 +1% 0.3% Moderate
    Dafna Capital ...

    72.8K $220,389 +1% 0.3% Moderate
    First Midwest ...

    49.4K $149,492 +1% 0.2% Low
    Susquehanna ...

    42.1K $127,576 +1% 0.2% Moderate

    Top Mutual Fund Holders
    Percentage of Outstanding Shares per Holdings Style

    Sector Specific 6.3%
    International 0.7%
    Specialty 0.0%
    Core Growth 0.0%
    Index 0.0%
    Low
    Avg. Turnover Rating

    Name
    Shares Held
    Position Value
    Percentage of
    Total Holdings
    since 2/4/15
    % Owned
    of Shares
    Outstanding Investment
    Style
    H&Q Healthcare ...

    828.4K $2,508,164 +10% 3.6% Sector Specific
    H&Q Life ...

    575.6K $1,742,961 +7% 2.5% Sector Specific
    FCP OP Medical ...

    164.4K $497,660 +2% 0.7% International
    PHARMA /wHEALTH Fund

    28.3K $85,737 0% 0.1% Sector Specific
    RIM Global Fund ...

    17.9K $51,357 0% 0.1% Sector Specific
    Fidelity NASDAQ ...

    5.0K $11,206 0% 0.0% Index
    CF Equities HAIG ...

    660.0 $1,483 0% 0.0% Core Growt

    Sentiment: Strong Buy

  • ajetjock ajetjock Feb 4, 2015 2:58 PM Flag

    The facts are obvious indeed, and 2015 shapes up to be a great year !

    Which is why I am here LONG tern.

    Sentiment: Strong Buy

  • ajetjock ajetjock Feb 4, 2015 1:15 PM Flag

    SamS.

    Don't confuse Peckstein with FACTS.

    He is interested in MANIPULATING the stock lower.

    FACTS, do not help his agenda.

    Sentiment: Strong Buy

  • ajetjock ajetjock Feb 4, 2015 11:26 AM Flag

    No kidding !

    Maybe TEVA should contact Peckstein Meifud and Gregory to get enlightened about slow release generic drugs .

    Hey Peckstein Meifud and Gregory, why don't you guys call TEVA ?

    Seriously though; You clowns are really a sad case of FAILED shorts pathetic stock manipulations attempts,

    Sentiment: Strong Buy

  • They tried to make investors believe that somehow IPCI has to refile its ANDAs...

    Obviously...

    Once AGAIN, the shorts bashers ended up with egg on their face.

    But don't assume they will stop lying and trying to create fear. Because that IS what they do !

    Even if REALITY conflicts with their made up stories and lies.

    Yesterday was just another one of these days:

    "IntelliPharmaCeutics International Inc. (IPCI) was a big mover last session, as the company saw its shares rise nearly 6% on the day. The upside was driven by the company’s announcement that it has signed an exclusive licensing and manufacturing agreement with Teva Pharmaceutical Industries Limited (TEVA) for an extended release oral drug product candidate. This led to solid volume too with far more shares changing hands than in a normal session."

    Sentiment: Strong Buy

  • Hang around internet board of a stock they hate and "enlighten" the rest of us, 24/7/365...

    These guys are practically saints.

    Not sure what religion...but saints they must be !

    ...or just IDIOTS with nothing better to do.

    You'll be the judge .

    Sentiment: Strong Buy

  • Reply to

    Brean Cap. on IPCI and TEVA partnership, the meat:

    by ajetjock Feb 3, 2015 10:51 AM
    ajetjock ajetjock Feb 3, 2015 12:00 PM Flag

    I suspect we are just STARTING to see the results of the new CFO.

    I would expect more such news and a great 2015 !

    Just think of the POTENTIAL of the pipeline...added to this partnership non of us was expecting.

    ...which is likely why the pathetic shorts are working "overtime". ;)

    One last point: As IPCI moves higher...and shorts starting to get SQUEEZED (Yummy !)and forced to buy IPCI and return shares the borrow... it will catapult the PPS even faster.

    Sentiment: Strong Buy

  • Reply to

    Anne C. Whitaker

    by johnamkins Jan 31, 2015 8:41 PM
    ajetjock ajetjock Feb 3, 2015 10:58 AM Flag

    Periods of no news are "open season" for shorts.

    Especially in biotechs...

    Being a LONG, I just wait it out. Thus far, nothing FUNDAMENTALLY has changed .

    Wait and accumulate.

    Sentiment: Strong Buy

  • Reply to

    Brean Cap. on IPCI and TEVA partnership, the meat:

    by ajetjock Feb 3, 2015 10:51 AM
    ajetjock ajetjock Feb 3, 2015 10:53 AM Flag

    More:

    , “Teva is not disclosing the specific drug candidate at this point due to competitive reasons, and we note that Intellipharmaceutics currently has 7 ANDAs under FDA review, with some of those ANDAs already substantially past the 35 months median review time for ANDAs. The FDA approved Intellipharmaceutics’ Toronto manufacturing facility in October 2014, about 3 years after the first approval in July 2011. As manufacturing facility approval is an integral part of drug approvals, we believe Intellipharmaceutics is well positioned for at least one ANDA approval this year. Currently, Intellipharmaceutics is partnered with Par to market generic Focalin XR in the US, but with more downstream economics from the Teva deal than from the Par deal, the Teva deal, in our view, will be more lucrative for Intellipharmaceutics.”

    Sentiment: Strong Buy

SCHN
15.27-0.10(-0.65%)Mar 27 4:00 PMEDT